Nicotine Polacrilex Gum, Chewing
Product Images NDC 70000-0348

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 70000-0348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 110, Llc. Dba Leader 70000, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Gum 2 mg And 4 mg Coated Ice Mint 1

Nicotine Gum 2 mg And 4 mg Coated Ice Mint 1
This is a product label for Nicotine Gum, a Stop Smoking Aid used to reduce withdrawal symptoms including craving associated with quitting smoking. The gum is meant to be used for at least 12 weeks with support from a program directed in the enclosed User's Guide. The gum is sugar-free and contains the active ingredient, Nicotine Polacrilex Gum USP, 2 mg which is coated with ice mint flavor. The label contains warnings for pregnant and breastfeeding women, as well as those with heart disease, high blood pressure, diabetes, and allergies. It also warns against using more than 4 pieces per day and for longer than the recommended period. The label includes directions for use, including a schedule for gradually reducing usage over 12 weeks.*
FDA Label Image

Nicotine Gum 2 mg And 4 mg Coated Ice Mint 2

Nicotine Gum 2 mg And 4 mg Coated Ice Mint 2
This is a product description for Nicotine Polacrilex Gum which is a stop smoking aid. It is advised to use at least 9 pieces per day for first week and to use it for a full 12 weeks for better results. The support program is directed as mentioned in the guide. The product contains 4mg of nicotine polacrilex in each chewing piece. It helps to reduce the withdrawal symptoms associated with quitting. The medicine should not be used during pregnancy or while breastfeeding without consulting a doctor. It also provides some directions for use along with warnings and precautions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.